Stem Cell Agency Chair Pressing for Consensus on IOM Recommendations
The chairman of the $3 billion California stem cell agency, Jonathan Thomas, yesterday outlined how he intends to proceed next week when the agency's governing board considers the far-reaching recommendations of a blue-ribbon Institute of Medicine panel.
Writing on the agency's blog, Thomas said,
“While some of the IOM’s recommendations are administrative…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.